Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1976 Nov;58(5):1069–1077. doi: 10.1172/JCI108558

Pulmonary abnormalities in intermediate alpha-1-antitrypsin deficiency.

W J Hall, R W Hyde, R H Schwartz, G S Mudholkar, D R Webb, Y P Chaubey, P L Townes
PMCID: PMC333273  PMID: 1086856

Abstract

Pulmonary function studies were carried out in a group of asymptomatic nonsmoking adults with intermediate alpha-1-antitrypsin deficiency who were attending an early disease detection unit in Rochester, N. Y. All subjects were identified by specific protease inhibitor (Pi) typing. Fifteen MZ and 14 MS subjects who had never smoked cigarettes were matched by sex and age to MM controls. Spirometry, static lung volumes, and single breath-diffusing capacity were identical in all Pi type groups with no statistically significant differences noted. Maximal expiratory flow volume curves were obtained in all subjects. MZ subjects demonstrated statistically impaired maximal flow rates at 75%, 50%, and 25% of vital capacity compared to their MM controls. Total pulmonary resistance by the oscillometric method was measured at 3, 5, 7, and 9 cycle/s in the same subjects. Increased frequency dependence of resistance (defined as the difference between total pulmonary resistance at 3 cycle/s and 9 cycle/s) was observed in MZ subjects compared to MM controls. No differences were noted by this method in MS-MM pairs. The data suggest that detectable mechanical abnormalities are present in subjects with the MZ phenotype, even in the absence of established risk factors such as cigarette smoking and high air pollution.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLAKEMORE W. S., FORSTER R. E., MORTON J. W., OGILVIE C. M. A standardized breath holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide. J Clin Invest. 1957 Jan;36(1 Pt 1):1–17. doi: 10.1172/JCI103402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barnett T. B., Gottovi D., Johnson A. M. Protease inhibitors in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1975 May;111(5):587–593. doi: 10.1164/arrd.1975.111.5.587. [DOI] [PubMed] [Google Scholar]
  3. Cooper D. M., Hoeppner V., Cox D., Zamel N., Bryan A. C., Levison H. Lung function in alpha1-antitrypsin heterozygotes (Pi type MZ). Am Rev Respir Dis. 1974 Dec;110(6):708–715. doi: 10.1164/arrd.1974.110.6P1.708. [DOI] [PubMed] [Google Scholar]
  4. DUBOIS A. B., BOTELHO S. Y., BEDELL G. N., MARSHALL R., COMROE J. H., Jr A rapid plethysmographic method for measuring thoracic gas volume: a comparison with a nitrogen washout method for measuring functional residual capacity in normal subjects. J Clin Invest. 1956 Mar;35(3):322–326. doi: 10.1172/JCI103281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. DUBOIS A. B., BOTELHO S. Y., COMROE J. H., Jr A new method for measuring airway resistance in man using a body plethysmograph: values in normal subjects and in patients with respiratory disease. J Clin Invest. 1956 Mar;35(3):327–335. doi: 10.1172/JCI103282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fagerhol M. K., Hauge H. E. Serum Pi types in patients with pulmonary diseases. Acta Allergol. 1969 May;24(2):107–114. doi: 10.1111/j.1398-9995.1969.tb03760.x. [DOI] [PubMed] [Google Scholar]
  7. Fagerhol M. K., Laurell C. B. The Pi system-inherited variants of serum alpha 1-antitrypsin. Prog Med Genet. 1970;7:96–111. [PubMed] [Google Scholar]
  8. Fagerhol M. K. Quantitative studies on the inherited variants of serum alpha-1-antitrypsin. Scand J Clin Lab Invest. 1969 Feb;23(1):97–103. doi: 10.3109/00365516909078092. [DOI] [PubMed] [Google Scholar]
  9. Fallat R. J., Powell M. R., Kueppers F., Lilker E. 133 Xe ventilatory studies in 1-antitrypsin deficiency. J Nucl Med. 1973 Jan;14(1):5–13. [PubMed] [Google Scholar]
  10. Goldman M., Knudson R. J., Mead J., Peterson N., Schwaber J. R., Wohl M. E. A simplified measurement of respiratory resistance by forced oscillation. J Appl Physiol. 1970 Jan;28(1):113–116. doi: 10.1152/jappl.1970.28.1.113. [DOI] [PubMed] [Google Scholar]
  11. Greenberg S. D., Jenkins D. E., Stevens P. M., Schweppe H. I. The lungs in homozygous alpha1 antitrypsin deficiency. Am J Clin Pathol. 1973 Nov;60(5):581–592. doi: 10.1093/ajcp/60.5.581. [DOI] [PubMed] [Google Scholar]
  12. Grimby G., Takishima T., Graham W., Macklem P., Mead J. Frequency dependence of flow resistance in patients with obstructive lung disease. J Clin Invest. 1968 Jun;47(6):1455–1465. doi: 10.1172/JCI105837. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hance A. J., Crystal R. G. The connective tissue of lung. Am Rev Respir Dis. 1975 Nov;112(5):657–711. doi: 10.1164/arrd.1975.112.5.657. [DOI] [PubMed] [Google Scholar]
  14. Higgins M., Keller J. Familial occurrence of chronic respiratory disease and familial resemblance in ventilatory capacity. J Chronic Dis. 1975 Apr;28(4):239–251. doi: 10.1016/0021-9681(75)90053-3. [DOI] [PubMed] [Google Scholar]
  15. Hyatt R. E., Black L. F. The flow-volume curve. A current perspective. Am Rev Respir Dis. 1973 Feb;107(2):191–199. doi: 10.1164/arrd.1973.107.2.191. [DOI] [PubMed] [Google Scholar]
  16. Interiano B., Hyde R. W., Hodges M., Yu P. N. Interrelation between alterations in pulmonary mechanics and hemodynamics in acute myocardial infarction. J Clin Invest. 1973 Aug;52(8):1994–2006. doi: 10.1172/JCI107384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. KORY R. C., CALLAHAN R., BOREN H. G., SYNER J. C. The Veterans Administration-Army cooperative study of pulmonary function. I. Clinical spirometry in normal men. Am J Med. 1961 Feb;30:243–258. doi: 10.1016/0002-9343(61)90096-1. [DOI] [PubMed] [Google Scholar]
  18. Klayton R., Fallat R., Cohen A. B. Determinants of chronic obstructive pulmonary disease in patients with intermediate levels of alpha-antitrypsin. Am Rev Respir Dis. 1975 Jul;112(1):71–75. doi: 10.1164/arrd.1975.112.1.71. [DOI] [PubMed] [Google Scholar]
  19. Kueppers F. Alpha-1-antitrypsin: physiology, genetics and pathology. Humangenetik. 1971;11(3):177–189. doi: 10.1007/BF00274738. [DOI] [PubMed] [Google Scholar]
  20. Kueppers F., Black L. F. Alpha1-antitrypsin and its deficiency. Am Rev Respir Dis. 1974 Aug;110(2):176–194. doi: 10.1164/arrd.1974.110.2.176. [DOI] [PubMed] [Google Scholar]
  21. Kueppers F., Dönhardt A. Obstructive lung disease in heterozygotes for alpha-1 antitrypsin deficiency. Ann Intern Med. 1974 Feb;80(2):209–212. doi: 10.7326/0003-4819-80-2-209. [DOI] [PubMed] [Google Scholar]
  22. Larson R. K., Barman M. L., Kueppers F., Fudenberg H. H. Genetic and environmental determinants of chronic obstructive pulmonary disease. Ann Intern Med. 1970 May;72(5):627–632. doi: 10.7326/0003-4819-72-5-627. [DOI] [PubMed] [Google Scholar]
  23. Laurell C. B. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem. 1966 Apr;15(1):45–52. doi: 10.1016/0003-2697(66)90246-6. [DOI] [PubMed] [Google Scholar]
  24. Lieberman J. Heterozygous and homozygous alpha-antitrypsin deficiency in patients with pulmonary emphysema. N Engl J Med. 1969 Aug 7;281(6):279–284. doi: 10.1056/NEJM196908072810601. [DOI] [PubMed] [Google Scholar]
  25. Lord G. P., Gazioglu K., Kaltreider N. The maximum expiratory flow-volume in the evaluation of patients with lung disease. A comparative study with standard pulmonary function tests. Am J Med. 1969 Jan;46(1):72–79. doi: 10.1016/0002-9343(69)90059-x. [DOI] [PubMed] [Google Scholar]
  26. Mead J. Contribution of compliance of airways to frequency-dependent behavior of lungs. J Appl Physiol. 1969 May;26(5):670–673. doi: 10.1152/jappl.1969.26.5.670. [DOI] [PubMed] [Google Scholar]
  27. Michaelson E. D., Grassman E. D., Peters W. R. Pulmonary mechanics by spectral analysis of forced random noise. J Clin Invest. 1975 Nov;56(5):1210–1230. doi: 10.1172/JCI108198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Mittman C., Lieberman J., Marasso F., Miranda A. Smoking and chronic obstructive lung disease in alpha-1-antitrypsin deficiency. Chest. 1971 Sep;60(3):214–221. doi: 10.1378/chest.60.3.214. [DOI] [PubMed] [Google Scholar]
  29. Mittman C., Lieberman J., Rumsfeld J. Prevalence of abnormal protease inhibitor phenotypes in patients with chronic obstructive lung disease. Am Rev Respir Dis. 1974 Feb;109(2):295–296. doi: 10.1164/arrd.1974.109.2.295. [DOI] [PubMed] [Google Scholar]
  30. Morris J. F., Koski A., Johnson L. C. Spirometric standards for healthy nonsmoking adults. Am Rev Respir Dis. 1971 Jan;103(1):57–67. doi: 10.1164/arrd.1971.103.1.57. [DOI] [PubMed] [Google Scholar]
  31. Morse J. O., Lebowitz M. D., Knudson R. J., Burrows B. A community study of the relation of alpha1-antitrypsin levels to obstructive lung diseases. N Engl J Med. 1975 Feb 6;292(6):278–281. doi: 10.1056/NEJM197502062920602. [DOI] [PubMed] [Google Scholar]
  32. OTIS A. B., MCKERROW C. B., BARTLETT R. A., MEAD J., MCILROY M. B., SELVER-STONE N. J., RADFORD E. P., Jr Mechanical factors in distribution of pulmonary ventilation. J Appl Physiol. 1956 Jan;8(4):427–443. doi: 10.1152/jappl.1956.8.4.427. [DOI] [PubMed] [Google Scholar]
  33. Ohlsson K. Neutral leucocyte proteases and elastase inhibited by plasma alpha 1 -antitrypsin. Scand J Clin Lab Invest. 1971 Nov;28(3):251–253. doi: 10.3109/00365517109095696. [DOI] [PubMed] [Google Scholar]
  34. Ostrow D. N., Cherniack R. M. The mechanical properties of the lungs in intermediate deficiency of 1 -antitrypsin. Am Rev Respir Dis. 1972 Sep;106(3):377–383. doi: 10.1164/arrd.1972.106.3.377. [DOI] [PubMed] [Google Scholar]
  35. Stein P. D., Leu J. D., Welch M. H., Guenter C. A. Pathophysiology of the pulmonary circulation in emphysema associated with alpha antitrypsin deficiency. Circulation. 1971 Feb;43(2):227–239. doi: 10.1161/01.cir.43.2.227. [DOI] [PubMed] [Google Scholar]
  36. Stevens P. M., Hnilica V. S., Johnson P. C., Bell R. L. Pathophysiology of hereditary emphysema. Ann Intern Med. 1971 May;74(5):672–680. doi: 10.7326/0003-4819-74-5-672. [DOI] [PubMed] [Google Scholar]
  37. Talamo R. C., Langley C. E., Levine B. W., Kazemi H. Genetic vs. quantitative analysis of serum alpha 1 -antitrypsin. N Engl J Med. 1972 Nov 23;287(21):1067–1069. doi: 10.1056/NEJM197211232872104. [DOI] [PubMed] [Google Scholar]
  38. Webb D. R., Hyde R. W., Schwartz R. H., Hall W. J., Condemi J. J., Townes P. L. Serum alpha 1-antitrypsin variants. Prevalence and clinical spirometry. Am Rev Respir Dis. 1973 Oct;108(4):918–925. doi: 10.1164/arrd.1973.108.4.918. [DOI] [PubMed] [Google Scholar]
  39. Welch M. H., Reinecke M. E., Hammarsten J. F., Guenter C. A. Antitrypsin deficiency in pulmonary disease: the significance of intermediate levels. Ann Intern Med. 1969 Sep;71(3):533–542. doi: 10.7326/0003-4819-71-3-533. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES